SEC Company Response from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) (AYTU) — Jan 14, 2020

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)
Date: Jan. 14, 2020 · CIK: 0001385818 · Accession: 0001213900-20-000997

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-235695

Date

January 14, 2020

Author

Joshua Disbrow

Form

CORRESP

Company

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)

Letter

Re: Aytu BioScience, Inc.

January 14, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-4 (File No. 333-235695)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement on Form S-4 (File No. 333-235695) be accelerated so that it will be declared effective at 11:00 AM EST on Wednesday, January 15, 2020 or as soon thereafter as is practicable.

Very truly yours,
Aytu BioScience, Inc.

Show Raw Text

CORRESP
1
filename1.htm

January 14, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Re: Aytu BioScience, Inc.

Registration Statement on Form S-4 (File No. 333-235695)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement on Form S-4
(File No. 333-235695) be accelerated so that it will be declared effective at 11:00 AM EST on Wednesday, January 15, 2020
or as soon thereafter as is practicable.

    Very truly yours,

    Aytu BioScience, Inc.

    By:
    /s/ Joshua Disbrow

    Name:
    Joshua Disbrow

    Title:
    Chief Executive Officer

SecProbe.io